Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep 1;100(9):851-857.
doi: 10.1097/PHM.0000000000001653.

Effectiveness of Botulinum Toxin A Injection in Managing Mobility-Related Outcomes in Adult Patients With Cerebral Palsy: Systematic Review

Nalinda D Andraweera  1 , Prabha H Andraweera, Zohra S Lassi, Venugopal Kochiyil
Affiliations

Effectiveness of Botulinum Toxin A Injection in Managing Mobility-Related Outcomes in Adult Patients With Cerebral Palsy: Systematic Review

Nalinda D Andraweera et al. Am J Phys Med Rehabil. .

Abstract

Purpose: Intramuscular botulinum toxin A (BTX-A) is used in the management of focal spasticity in cerebral palsy (CP). The aim was to conduct a systematic review to assess current literature on the use of BTX-A in the management of mobility-related outcomes among adult persons with spastic CP.

Methods: All studies reporting on the use of BTX-A in the management of spastic CP among adult persons were identified by searching the following electronic databases: PubMed, CINAHL, the Cochrane Library, and EMBASE.

Results: Six studies were included in the review. Most studies were conducted in mixed patient groups comprising patients with movement disorders, traumatic brain injury, CP, and other disorders requiring therapy for spasticity. BTX-A was shown to be effective in improving spasticity-related outcomes among persons with CP, but mixed results were shown for functional outcomes.

Conclusions: More studies are required on exclusive CP cohorts using recommended and currently used scales, incorporating quality of life and patient satisfaction scales. Results from long-term follow-up studies will be valuable for better evaluation of the effectiveness of BTX-A in the management of spasticity-related outcomes among adult persons with CP.

PubMed Disclaimer

Conflict of interest statement

Financial disclosure statements have been obtained, and no conflicts of interest have been reported by the authors or by any individuals in control of the content of this article.

Similar articles

See all similar articles

Cited by

References

    1. Tonmukayakul U, Shih STF, Bourke-Taylor H, et al.: Systematic review of the economic impact of cerebral palsy. Res Dev Disabil 2018;80:93–101
    1. Marchiori C, Roche N, Vuillerme N, et al.: Effect of multisite botulinum toxin injections on gait quality in adults with cerebral palsy. Disabil Rehabil 2014;36:1971–4
    1. Bergfeldt U, Borg K, Kullander K, et al.: Focal spasticity therapy with botulinum toxin: Effects on function, activities of daily living and pain in 100 adult patients. J Rehabil Med 2006;38:166–71
    1. Solanke F, Colver A, McConachie H; Transition collaborative group: Are the health needs of young people with cerebral palsy met during transition from child to adult health care? Child Care Health Dev 2018;44:355–63
    1. Binks JA, Barden WS, Burke TA, et al.: What do we really know about the transition to adult-centered health care? A focus on cerebral palsy and spina bifida. Arch Phys Med Rehabil 2007;88:1064–73

Publication types

MeSH terms

Substances